ASHLEY NICOLE COURCHESNE

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Family NEW BRAUNFELS, TX NPI 1922528645

General Payments — all program years on this page

$3,737.69

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 193
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $643.14 across 19 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $643.1419

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $803.4441
2022 $1,406.3791
2023 $884.7442
2024 $643.1419

Records — PY2024 (19)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1139144146 Tarsus Pharmaceuticals, Inc. $117.45 11/20/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145351581 Galderma Laboratories, L.P. $9.16 02/06/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145351583 Galderma Laboratories, L.P. $112.02 06/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145351585 Galderma Laboratories, L.P. $15.35 06/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1145351587 Galderma Laboratories, L.P. $8.65 06/27/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146378874 MERZ NORTH AMERICA, INC. $43.72 07/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146378876 MERZ NORTH AMERICA, INC. $90.64 05/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147937121 REVANCE THERAPEUTICS, INC. $31.25 04/30/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147937123 REVANCE THERAPEUTICS, INC. $21.72 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147937125 REVANCE THERAPEUTICS, INC. $32.58 05/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147937127 REVANCE THERAPEUTICS, INC. $31.52 06/11/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147937129 REVANCE THERAPEUTICS, INC. $17.61 09/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147937131 REVANCE THERAPEUTICS, INC. $17.67 10/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147937133 REVANCE THERAPEUTICS, INC. $8.89 10/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147937135 REVANCE THERAPEUTICS, INC. $16.91 10/31/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147937137 REVANCE THERAPEUTICS, INC. $3.99 11/08/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147937139 REVANCE THERAPEUTICS, INC. $15.73 11/22/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147937141 REVANCE THERAPEUTICS, INC. $23.28 12/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1147937143 REVANCE THERAPEUTICS, INC. $25.00 12/13/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.